Intravenous Immunoglobulin and Guillain-Barré Syndrome

By Harel Michal   Shoenfeld Yehuda  

Clinical Reviews in Allergy and Immunology, Vol. 29, Iss. 3, 2005-12 ,pp. : 281-288

Humana Press, Inc

Access to resources Recommend Favorite

A retrospective survey of the quality of reports and their correlates among randomized controlled trials of immunotherapy for Guillain-Barré syndrome

By Lu Liming   Luo Gaoquan   Xiao Fang  

Immunotherapy, Vol. 5, Iss. 8, 2013-08 ,pp. : 829-836

Future Medicine

Access to resources Recommend Favorite

Recovery from Guillain–Barré Syndrome Is Associated with Increased Levels of Neutralizing Autoantibodies to Interferon-&ggr;

By Elkarim R.A.   Dahle C.   Mustafa M.   Press R.   Zou L-P.   Ekerfelt C.   Ernerudh J.   Link H.   Bakhiet M.  

Clinical Immunology, Vol. 88, Iss. 3, 1998-09 ,pp. : 241-248

Academic Press

Access to resources Recommend Favorite

Increased Circulating Th17 Cell Populations and Elevated CSF Osteopontin and IL-17 Concentrations in Patients with Guillain-Barré Syndrome

By Han Rong   Cheng Yue   Zhou Shan   Guo Hong   He Rui   Chi Li   Zhang Li  

Journal of Clinical Immunology, Vol. 34, Iss. 1, 2014-01 ,pp. : 94-103

Springer Publishing Company

Access to resources Recommend Favorite

Treatment of the adult Guillain-Barre syndrome: indications for plasma exchange

By Raphael J.-C.   Chevret S.   Auriant I.   Sharshar T.   Bouget J.   Bolgert F.  

Transfusion and Apheresis Science, Vol. 20, Iss. 1, 1999-02 ,pp. : 53-61

Elsevier

Access to resources Recommend Favorite